Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain. - Wikidata - awgldk - TriplyDB

Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain.

Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain.

http://www.wikidata.org/entity/Q36018770

about

Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposal Advances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2 Experimental Infection of Calves with Escherichia coli O104:H4 outbreak strain Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak [Treatment of typical hemolytic-uremic syndrome. Knowledge gained from analyses of the 2011 E. coli outbreak].Microbes without frontiers: severe haemolytic-uraemic syndrome due to E coli O104:H4.[Management of patients with EHEC/HUS. Lessons and perspectives from clinical infectious disease specialists].Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea.Duration of fecal shedding of Shiga toxin-producing Escherichia coli O104:H4 in patients infected during the 2011 outbreak in Germany: a multicenter study.Symptoms and clinical course of EHEC O104 infection in hospitalized patients: a prospective single center study New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome Enterohemorrhagic Escherichia coli as causes of hemolytic uremic syndrome in the Czech Republic.Cyclic-di-GMP signalling and biofilm-related properties of the Shiga toxin-producing 2011 German outbreak Escherichia coli O104:H4.Shigella sonnei and hemolytic uremic syndrome: A case report and literature review.Phenethyl isothiocyanate inhibits shiga toxin production in enterohemorrhagic Escherichia coli by stringent response induction.Frequency of shiga toxin-producing genes of Escherichia coli isolated from diarrheic stools of Iranian children by PCR Effects of Shiga toxin type 2 on maternal and fetal status in rats in the early stage of pregnancy.Zinc protects against Shiga-toxigenic Escherichia coli by acting on host tissues as well as on bacteria.Bacteriophages Contribute to the Spread of Antibiotic Resistance Genes among Foodborne Pathogens of the Enterobacteriaceae Family - A Review.Haemolytic-uraemic syndrome with bacteraemia caused by a new hybrid Escherichia coli pathotype.A comparison of Shiga-toxin 2 bacteriophage from classical enterohemorrhagic Escherichia coli serotypes and the German E. coli O104:H4 outbreak strain.Spread of a distinct Stx2-encoding phage prototype among Escherichia coli O104:H4 strains from outbreaks in Germany, Norway, and Georgia.Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak.Recent advances in understanding enteric pathogenic Escherichia coli.Lability of the pAA Virulence Plasmid in Escherichia coli O104:H4: Implications for Virulence in Humans.Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin.Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunity Genetic Diversity and Antibiotic Resistance of Escherichia coli Isolates from Different Leafy Green Production Systems.Antimicrobial resistance profiles of Shiga toxin-producing Escherichia coli O157 and Non-O157 recovered from domestic farm animals in rural communities in Northwestern Mexico Lessons Learned From Outbreaks of Shiga Toxin Producing Escherichia coli Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.Different Effects of Six Antibiotics and Ten Traditional Chinese Medicines on Shiga Toxin Expression by Escherichia coli O157:H7 Enterohemorrhagic Escherichia coli Hybrid Pathotype O80:H2 as a New Therapeutic Challenge Identification of a New Virulent Clade in Enterohemorrhagic Escherichia coli O26:H11/H- Sequence Type 29.Rifaximin: beyond the traditional antibiotic activity.Intrahost milieu modulates production of outer membrane vesicles, vesicle-associated Shiga toxin 2a and cytotoxicity in Escherichia coli O157:H7 and O104:H4.Antibiotic-Mediated Modulations of Outer Membrane Vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7.Polysorbates prevent biofilm formation and pathogenesis of Escherichia coli O104:H4.

P2860

Q26775927-B4505F48-3A9D-41AC-AC53-EE7C77EC4E0C Q26827657-A67E3F98-7215-4AC1-88F9-52C08F1A8457 Q26863602-40B6D5B9-473B-4EE9-B713-189A4C3E53A9 Q27312492-A4CF1C3C-CF13-4191-9A95-76782062CA8B Q33402456-829BF314-A227-4C1D-A576-88D6397014E9 Q33402995-6F579A5B-5A84-4C5A-B642-744CE83C5377 Q33404545-728F47CB-F22A-4906-AAF2-89567DB9DC86 Q33404955-7D3AE875-DCD7-4307-A5FF-CCAACCD98F38 Q33405034-4BA4E3BE-F907-4187-BC2F-F89EF91548BA Q33405117-2D56F8BB-5A27-4373-AF04-7116C3662DED Q33405183-E3ED5E2F-5031-4543-8510-B67F73205777 Q33406247-00D03695-2282-4B09-8737-A3D9D0DE50EA Q33409878-465CEE3F-F401-44D6-8858-90A061AFB700 Q33410364-34EC0956-8DBF-476A-B16A-9D9776F14114 Q33418487-61FCAC8C-75BB-4E34-8D89-29E7A380B139 Q33439653-9773BB92-D683-4BDF-AE11-C6F6B7E7ADEC Q33623008-ECA176D8-1846-4078-A6C4-77DB4432734D Q33628277-C20E95E1-FC41-47A5-8F92-52F703B12202 Q33634763-FA03F66B-7C73-4F3E-8E4E-2A699D8C780C Q33811599-795121B3-B1E9-4AB4-A43B-0C5B01D5DAC2 Q33813037-DB02C332-9176-4E41-B609-B755E7429232 Q34286494-D6607A5A-6AC9-4449-BC62-8AC2FFB00D05 Q34287467-23ACE91C-6D6D-4C5E-B7E7-3667B8B3F59F Q34343454-0795760D-7039-4129-898E-EC9870B8695D Q34361876-733BFEA0-83C7-483D-9E9E-E0F5E2581159 Q34375210-5443DCD9-701D-423C-8834-E87D9CBBE5A9 Q34785544-52F1253C-2E40-4A03-AC73-163407AD8504 Q35673972-CC6F3C96-3355-4A59-BAFB-CB6EE90CA197 Q35677483-4CFF1906-6BD2-42A2-950B-74FCBECC4742 Q36286096-5D368FD5-F60B-4B68-B5C2-C94C52DCEBB3 Q36428589-97EF485B-EBD7-4041-82ED-CC78DCFD3EB9 Q36563022-55F51FBD-2647-47A0-B6BE-8BF2B0E076CD Q36837884-5810F553-6902-4971-9D8B-FC487EBA16BF Q37061361-1F0DF546-8BE4-49EF-B392-0AD37526F026 Q37196271-6C4B9777-C698-4847-A39A-07E0675DEFB4 Q37661384-79CD6FDA-E76A-4ECC-882A-43FBBDA44FFE Q38237218-4D181B68-DCA4-416E-AE6C-8A1BE4BCA745 Q38694507-29DD6A0F-6EC8-4214-9414-D6D84C790D25 Q38729028-7543D42F-9F7A-4F3D-8278-0D86112152A5 Q38817818-59191B9E-DABD-47ED-B3CD-C8BC1CBE5FE2

P2860

Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain.

http://www.wikidata.org/entity/Q36018770

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Effects of antibiotics on Shig ...... cherichia coli O104:H4 strain.

@ast

Effects of antibiotics on Shig ...... cherichia coli O104:H4 strain.

@en

type

label

Effects of antibiotics on Shig ...... cherichia coli O104:H4 strain.

@ast

Effects of antibiotics on Shig ...... cherichia coli O104:H4 strain.

@en

prefLabel

Effects of antibiotics on Shig ...... cherichia coli O104:H4 strain.

@ast

Effects of antibiotics on Shig ...... cherichia coli O104:H4 strain.

@en

P1433

Q36018770-1297C792-DF0D-4463-BA7B-EACABA28B512

P1476

Q36018770-C4C83CBB-1B2F-45D1-88FB-1DFFE01D6B3F

P2093

Q36018770-1867F9C9-28A3-4BC4-9A2B-B580664E93CA

Q36018770-27AD1C4A-EACF-4114-B71B-E606FC36C586

Q36018770-6B6E788F-D1A2-4212-A115-0AC488785E02

Q36018770-A77D9F42-F0C6-48C0-86E7-8482D655A536

Q36018770-B4D4E869-AA3A-4B1A-9B15-7F566481942D

Q36018770-C953D7E9-E9E5-465C-81CB-F22090DD2D24

P2860

Q36018770-001283B7-D029-4722-A792-2AFF3B9ACD98

Q36018770-09FEC820-E0CC-4905-8978-27075499555B

Q36018770-2363D80F-0374-4C72-9487-A6C6BC5DF24D

Q36018770-283200DA-C3DD-4AD9-B591-14AA98A9FB6B

Q36018770-28DE8DD8-55CD-43C9-8013-7CA3B45C5244

Q36018770-32A0988B-0BED-4386-A3BF-0CFD7F7BCC9C

Q36018770-425D7A12-0A1F-4241-9AB2-BD962E2D4AEF

Q36018770-4382C822-9A37-4EAF-B340-5CD551E6910E

Q36018770-5B0FE568-35FF-48AA-B2A2-10E1A4ADCAE0

Q36018770-60262A8A-250E-434B-9D41-DF57ED42F52D

P304

Q36018770-8CC5F465-9AC9-44C9-A83B-AFE4B7EC12C6

P31

Q36018770-1D4676F8-E186-4BB8-9764-7BFB6292DF52

P356

Q36018770-58749FFD-92A0-41EC-9051-892A8735881E

P407

Q36018770-E0765F87-A657-49A4-B519-4DD906C9B31C

P433

Q36018770-B54ACE2C-A1E0-4333-90B0-373BF7A29E37

P478

Q36018770-808D0DF8-0E2B-4E3D-9817-7002378A3450

P50

Q36018770-74885023-B229-470C-A613-B08477C7A11F

Q36018770-EBFAB18E-0D1B-409F-A786-CB1263061D7B

P577

Q36018770-3EBA028C-6B63-4D47-A24E-0C42812A7093

P698

Q36018770-5A583141-FB5B-4A88-BC76-DCFC3265A946

P921

Q36018770-0B423F1B-D8BA-4F1A-A985-595FB1E681D1

Q36018770-50624511-7B77-4305-AA77-AA27FEEECBC2

P932

Q36018770-16120E6F-0036-4AE6-9394-DFAC4D2256C0

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Effects of antibiotics on Shig ...... cherichia coli O104:H4 strain.

@en

P2093

Andreas Bauwens

http://www.w3.org/2001/XMLSchema#string

Evgeny A Idelevich

http://www.w3.org/2001/XMLSchema#string

Frieder Schaumburg

http://www.w3.org/2001/XMLSchema#string

Georg Peters

http://www.w3.org/2001/XMLSchema#string

Martina Bielaszewska

http://www.w3.org/2001/XMLSchema#string

Wenlan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response

Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany.

The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Enterohaemorrhagic Escherichia coli in human medicine.

Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis.

Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli.

Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli.

P304

3277-3282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.06315-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Mellmann

P577

2012-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22391549

http://www.w3.org/2001/XMLSchema#string

P921

P932

3370775

http://www.w3.org/2001/XMLSchema#string